1.1.99.36	1-butanol	substrate inhibition	556	
1.1.99.36	1-propanol	substrate inhibition	660	
1.1.99.36	2-butanol	substrate inhibition	1132	
1.1.99.36	2-propanol	substrate inhibition	682	
1.1.99.36	acetaldehyde	1 mM, 40% inhibition; 40% inhibition at 1 mM, 60% at 2 mM, and 95% at 10 mM	90	
1.1.99.36	ADP	10% inhibition at 1 mM, 50% at 10 mM	13	
1.1.99.36	AMP	10% inhibition at 1 mM, 50% at 10 mM	30	
1.1.99.36	ATP	10% inhibition at 1 mM, 50% at 10 mM	4	
1.1.99.36	Cu2+	1 mM, 90% inhibition; 90% inhibition at 1 mM	19	
1.1.99.36	ethanol	substrate inhibition	69	
1.1.99.36	Fe2+	1 mM, 90% inhibition; 90% inhibition at 1 mM	25	
1.1.99.36	Hg2+	100% inhibition at 1 mM	33	
1.1.99.36	Isobutyramide	competitive to N,N-dimethyl-4-nitrosoaniline	2339	
1.1.99.36	KCN	2 mM, 90% inhibition; 90% inhibition at 2 mM	161	
1.1.99.36	additional information	NAD(H) and NADP(H) do neither inhibit nor stimulate NDMA-ADH activity; NAD(H) and NADP(H) neither inhibit nor stimulate NDMA-ADH activity	2	
1.1.99.36	NaN3	25% inhibition at 2 mM; 2 mM, 25% inhibition	238	
1.1.99.36	Ni2+	15% inhibition at 1 mM	38	
1.1.99.36	trans-4-(N,N-dimethylamino)-cinnamaldehyde	inhibition through direct binding to the catalytic zinc ion in a substrate-like geometry. This binding is accompanied by a characteristic red shift of the aldehyde absorbance from 398 nm to 467 nm	13226	
1.1.99.36	trifluoroethanol	nonreactive substrate analogue, competitive to ethanol	11162	
1.1.99.36	Zn2+	1 mM, 40% inhibition; 40% inhibition at 1 mM	14